Shares of Dr Reddy's Laboratories soared 10 percent to hit a record high of Rs 5,302.85 after the pharma company informed the settlement of their litigation with Celgene, a wholly-owned subsidiary of Bristol Myers Squibb, relating to patents for REVLIM (lenalidomide)
from Latest Business News | Finance News India | International Share Market – Oneindia Money https://ift.tt/33CJltf
from Latest Business News | Finance News India | International Share Market – Oneindia Money https://ift.tt/33CJltf